Account
Inquiry
Tirzepatide 10mg is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for research into type 2 diabetes and weight management applications. This synthetic peptide demonstrates superior efficacy in glucose control and weight reduction compared to single agonists.
The molecular structure of tirzepatide 10mg features a lysine side chain with PEG modification, enhancing water solubility while maintaining biological activity. Clinical studies have shown significant weight reduction potential, with research subjects demonstrating average weight loss of 15-20% in controlled trials.
As a research chemical, tirzepatide 10mg offers scientists a valuable tool for investigating metabolic disorders. The compound's unique dual agonist mechanism provides distinct advantages for studying glucose metabolism and adipose tissue regulation.
Our tirzepatide 10mg is supplied as a lyophilized white powder with guaranteed 99.9% purity, packaged in sterile vials suitable for research applications. Each batch undergoes rigorous quality control testing to ensure consistency and reliability for scientific studies.
